Cena / výnosy společnosti Apollo Endosurgery Inc
Jaká je hodnota metriky Cena / výnosy společnosti Apollo Endosurgery Inc?
Hodnota metriky Cena / výnosy společnosti Apollo Endosurgery Inc je 5.09
Jaká je definice metriky Cena / výnosy?
Cena / výnosy (Price to sales ratio) je ukazatel,který představuje cenu společnosti ve srovnání s výškou její tržeb.
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Cena / výnosy společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Apollo Endosurgery Inc
Čemu se věnuje společnost Apollo Endosurgery Inc?
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
Firmy s metrikou cena / výnosy podobnou společnosti Apollo Endosurgery Inc
- Hodnota metriky Cena / výnosy společnosti IFA Hotel & Touristik Aktiengesellschaft je 5.09
- Hodnota metriky Cena / výnosy společnosti Red Violet Inc je 5.09
- Hodnota metriky Cena / výnosy společnosti Allspring Global Dividend Opportunity Fund je 5.09
- Hodnota metriky Cena / výnosy společnosti Garware Technical Fibres je 5.09
- Hodnota metriky Cena / výnosy společnosti 49 North Resources je 5.09
- Hodnota metriky Cena / výnosy společnosti Kings Infra Ventures je 5.09
- Hodnota metriky Cena / výnosy společnosti Apollo Endosurgery Inc je 5.09
- Hodnota metriky Cena / výnosy společnosti Norfolk Southern je 5.09
- Hodnota metriky Cena / výnosy společnosti Boston Scientific je 5.09
- Hodnota metriky Cena / výnosy společnosti Iradimed Corp je 5.10
- Hodnota metriky Cena / výnosy společnosti Basellandschaftliche Kantonalbank je 5.10
- Hodnota metriky Cena / výnosy společnosti China U-Ton je 5.10
- Hodnota metriky Cena / výnosy společnosti Pool Safe je 5.10